At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
09688 ZAI LAB
Not Yet Opened 12-11 16:08:03
13.920
-0.340
-2.38%
High14.420
Low13.800
Vol13.05M
Open14.250
D1 Closing14.260
Amplitude4.35%
Mkt Cap15.59B
Tradable Cap15.59B
Total Shares1.12B
T/O182.63M
T/O Rate1.16%
Tradable Shares1.12B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Hong Kong Stocks Hit 52-Week Highs and Lows | Dec 11
BRIEF-Zai Lab Announces Dosing Of First Participant In Global Phase 1/1b Study Of ZL-1503, An IL-13/IL-31R Bispecific Antibody For Treatment Of Atopic Dermatitis
Zai Lab Announces Dosing of First Participant in Global Phase 1/1B Study of Zl-1503, an Il-13/Il-31R Bispecific Antibody for the Treatment of Atopic Dermatitis
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.